Daniel Lochner | Chief Financial Officer |
Jeffrey Nau | President and Chief Executive Officer |
Tyler Van Buren | Piper Sandler |
Georgi Yordanov | Cowen and Company |
Tess Romero | JP Morgan |
Good evening, everyone, and welcome to Oyster Point Pharma's Fourth Quarter and Full Year 2019 Conference Call.
Today, after the close, we issued a press release containing fourth quarter and full year 2019 financial results and recent business highlights. This press release is available on our website under the Investor and News section at www.oysterpointrx.com.
Joining us on the call today is Dr. Jeffrey Nau, President and Chief Executive Officer of Oyster Point Pharma.